| |
|
|
|
Redhill Biophrma ADR  
|
|
6.9101 -0.33 (-0.05%) |
05-23 12:17 |
|
Open: |
6.89 |
Pre close: |
7.24 |
Target:
|
8.58
|
|
High: |
7.03 |
Low: |
6.75 |
Resistance:
|
7.35
8.58
|
|
Volume: |
92,768 |
Market Cap: |
144M |
Support:
|
5.71
 4.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.04
 |
MACD |
MACD(12,26):
|
0.53 |
|
MA(20): |
5.98 |
Signal(12,26,9): |
0.40 |
|
MA(100): |
5.66 |
Stochastic Oscillator |
%K(14,3):
|
90.61 |
|
MA(250): |
7.10 |
%D(3): |
91.69 |
|
Average Volume(K) |
3-Month: |
8355
|
52-Week |
High:
|
11.25 |
|
10-Days: |
17908 |
Low: |
4.30 |
|
RSI |
RSI(14):
|
69.21 |
Change(%): |
-30.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.500 |
Return on Equity (ttm) |
-98.5 |
Shares Out. (M) |
21.34 |
|
EPS Est. Current Year |
-2.390 |
Return on Assets (ttm) |
-80.8 |
Shares Float (M) |
21.34 |
|
EPS Est. Next Year |
-0.540 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.620 |
Qtrly Rev. Growth |
1901.0 |
% Held by Institutions |
14.00 |
|
Forward EPS |
-0.320 |
Gross Profit (p.s.) |
0.037 |
Shares Short (K) |
329 |
|
Book Value (p.s.) |
3.560 |
EBITDA (p.s.) |
-1.161 |
P/E |
-2.76 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.94 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-44.77 |
P/S |
5157863936.00 |
|
Operating Margin |
-1275.94 |
Levered Free Cash Flow
(M) |
-28.20 |
P/CF |
-3.29 |
|
|
|
|
|
|
